Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Non-GCB cell of origin leads to inferior outcomes in brazilian diffuse large B-cell lymphoma patients: Bra-DLBCL multicenter registry, retrospective study of over 500 patients

Guilherme Perini, Larissa Teixeira, Carolina Feres, Talita Silveira, Rafael Gaiolla, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 6323.

https://doi.org/10.1182/blood-2025-6323

Published: 2025

Journal Articles

The impact of public versus private health care services in the treatment of diffuse large B-cell lymphoma in Brazil: An analysis from the bra-DLBCL multicenter, retrospective real-world registry

Talita Silveira, Guilherme Perini, Larissa Teixeira, Carolina Feres, Rafael Gaiolla, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 8011.

https://doi.org/10.1182/blood-2025-8011

Published: 2025

Journal Articles

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Gabriel Cunha, Pedro Perez, Fernanda Marques, Verena Pfister, Rodrigo Santucci, Milton Aranha, Danielle De Farias, Talita Silveira, Jayr Schmidt Filho, Valeria Buccheri, Roberto Silva, Leila Perobelli, Glaciano Ribeiro, Maura Colturato, Nelson Hamerschlak, Pedro Fernandes, Fernanda Santos Azevedo, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2025) 146 (Supplement 1): 3909.

https://doi.org/10.1182/blood-2025-3909

Published: 2025

Journal Articles

Outcomes of diffuse large B-cell lymphoma and high-grade B-cell lymphoma in elderly patients aged ≥ 80 years-old treated in first line therapy: An analysis of the bra-DLBCL multicenter, real-world registry, retrospective study

Carolina Feres, Guilherme Perini, Larissa Teixeira, Rafael Gaiolla, Talita Silveira, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 8070.

https://doi.org/10.1182/blood-2025-8070

Published: 2025

Journal Articles

Analysis of lymphoma subtypes, involved sites, and treatment outcomes in primary gastrointestinal B-cell lymphomas: A subset analysis within the PELÉ study of brazilian centers.

Blood (2025) 146 (Supplement 1): 2760.

https://doi.org/10.1182/blood-2025-2760

Published: 2025

Journal Articles

The impact of high-grade B-cell lymphoma morphology compared with diffuse large B-cell lymphoma in a cohort from bra-DLBCL, a multicenter, real-world study from Brazil

Rafael Gaiolla, Talita Silveira, Carolina Feres, Larissa Teixeira, Frederico Lisboa Nogueira, Juliana Rocha, Maria Dias, Marianna Batista Vieira Lima, Andrea Souza, Elice Batista, Frederico Monfardini, Alice Bianco, Guilherme Perini, Leonardo Arcuri

Blood (2025) 146 (Supplement 1): 8102.

https://doi.org/10.1182/blood-2025-8102

Published: 2025

Journal Articles

First-line venetoclax-based regimens versus chemoimmunotherapy in chronic lymphocytic leukemia: A real-world analysis from the brazilian CLL registry

Samir Nabhan, Gabriel Cunha, Verena Pfister, Leila Perobelli, Erika Oshiro, Rodrigo Santucci, Milton Aranha, Talita Silveira, Jayr Schmidt Filho, Danielle De Farias, Cristiana Solza, Valeria Buccheri, Thiago Carneiro, Vera Figueiredo, Maura Colturato, Abel Costa, Fernanda Marques, Caio Cesar Justino, Celso Arrais-Rodrigues

Blood (2025) 146 (Supplement 1): 7413.

https://doi.org/10.1182/blood-2025-7413

Published: 2025

Journal Articles

Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.

Thomas Chatzikonstantinou, Persefoni Talimtzi, Eva Minga, Maria Angelopoulou, Miguel Arguello De Tomas, Darko Antic, Celso Arrais-Rodrigues, Francesc Bosch Albareda, Marcello Bradaschia, Alessandro Cellini, Mark Catherwood, Sophia Chatzileontiadou, Caterina Chessa, Carlos Chiattone, Rosa Collado, Marta Coscia, Marta Crespo, Antonio Cuneo, Zadie Davis, Maria Dimou, Michael Doubek, Maria Efstathopoulou, Blanca Espinet, Gianluca Gaidano, Rocio Garcia-Serra, Alessandro Gozzetti, Ritu Gupta, Eleftheria Hatzimichael, Yair Herishanu, Ozren Jaksic, Maria Kislova, Eliana Konstantinou, Sevasti Konstantinou, Maya Koren Michowitz, Ioannis Kotsianidis, Andreas Epameinondas Koumpis, Luca Laurenti, Alexandros Machairas, Francesca Martini, Riccardo Moia, Samir Mouhssine, Ana Muntanola Prat, Roberta Murru, Rocio Nieves Salgado Sanchez, Gerassimos Pangalis, Maria Papaioannou, Sarka Pavlova, Leila Perobelli, Sarka Pospisilova, Anna Puiggros, Claus Rainer, Sergio Ramos, Lata Rani, Gian Matteo Rigolin, Ilaria Romano, Davide Rossi, Rodrigo Santucci, Angel Serna, Marina Siakantaris, Talita Silveira, Paolo Sportoletti, Niki Stavrogianni, Annamaria Tomasso, Kristina Tomic Vujovic, Livio Trentin, Theodoros Vassilakopoulos, Andrea Visentin, Candida Vitale, George Vrachiolias, Munci Yagci, Seyma Yildiz, Anastasia Chatzidimitriou, Kostas Stamatopoulos, Paolo Ghia, Lydia Scarfo

Blood (2025) 146 (Supplement 1): 5664.

https://doi.org/10.1182/blood-2025-5664

Published: 2025

Journal Articles

Allogenic Transplant in Mycosis Fungoides: Never or Never Too Late?Brazilian Single Center Experience

Ana Luisa Oliveira, Thais Fischer, Julia Aith Balthazar, Lais Lie Abrantes, Jayr Schmidt Filho, Talita Silveira

Blood (2024) 144 (Supplement 1): 6424.

https://doi.org/10.1182/blood-2024-212143

Published: 2024

Journal Articles

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Verena Pfister, Fernanda de Morais Marques, Vinicius Campos de Molla, Flavia Parra, Mihoko Yamamoto, Rodrigo Santucci, Milton A. F. Aranha, Valeria Buccheri, Glaciano Ribeiro, Vera Figueiredo, Nelson Hamerschlak, Abel Costa Neto, Jayr Schmidt Filho, Talita Silveira, Adriana Scheliga, Matheus Vescovi Goncalves, Leila Perobelli, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2024) 144 (Supplement 1): 2348.

https://doi.org/10.1182/blood-2024-210706

Published: 2024

Journal Articles

Adult T-Cell Leukemia/Lymphoma: A Cohort of 41 Cases Recorded in the Brazilian T-Cell Project

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-142818

Published: 2020

Journal Articles

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Fernanda de Morais Marques, Verena Pfister, Flavia Parra, Mihoko Yamamoto, MD PhD, Rodrigo Santucci Silva, MD, Marcelo Bellesso, MD, Vinicius Campos de Molla, MD, Ana Rita Da Fonseca, MD, Yana Novis, MD, Sérgio Costa Fortier, MD, Talita Silveira, MD PhD, Guilherme Brasil Duffles Amarante, MD, Valeria Buccheri, Matheus Vescovi, MD PhD, Carlos Sérgio Chiattone, MD PhD, Celso Arrais, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142810

Published: 2020

Journal Articles

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-142520

Published: 2020

Journal Articles

Real Life CNS-IPI Score Validation: A Retrospective Analysis of Two Centers in Brazil Outside of Clinical Trial

Thais Fischer, MD, Natalia Pin Chuen Zing, MD, Sérgio Costa Fortier, MD, Talita Silveira, Carlos Sérgio Chiattone, MD

Blood (2019) 134 (Supplement_1): 4133.

https://doi.org/10.1182/blood-2019-125576

Published: 2019

Journal Articles

Obinutuzumab for CLL Relapsed and Refractory Patients When New Oral Drugs an Not Available

Laura Fogliatto, MD, Kamila Grokoski, Ana Segatto, Mirna Philipp, Jorge Vaz Pinto Neto, Eugenio Escovar, Yuri Vasconcelos, MDPhD, Jair Schimidt Filho, Talita Silveira, Tania Hellwig, Christina Fraga

Blood (2017) 130 (Supplement 1): 5341.

https://doi.org/10.1182/blood.V130.Suppl_1.5341.5341

Published: 2017

Journal Articles

IgA Levels Can Predict Survival in CLL Patients: A Retrospective Analysis of 183 Cases in a Brazilian Cohort

Sérgio Costa Fortier, MD, Natália Zing, MD, Fabio Lima da Silva, MD, Viviane Mayumi Endo, Talita Silveira Da Rocha, MD, Bárbara Tannus, MD, Maeva Pinto, MD, Carlos Chiattone, MD PhD

Blood (2015) 126 (23): 5284.

https://doi.org/10.1182/blood.V126.23.5284.5284

Published: 2015

Journal Articles

The Oral Mtor Inhibitor Everolimus in Relapsed and Refractory Hodgkin Lymphoma- Compassionate Use in 8 Centers in Brazil

Talita Silveira Da Rocha, MD, Sergio Costa Fortier, MD, Nelson Siqueira de Castro, MD, Marcia T Delamain, MD, José Salvador Oliveira, PhD, Guilherme Perini, MD, Valeria Buccheri, PhD, Rafael Dezen Gaiolla, MD, Laura Fogliato, PhD, Andressa Laranja, Maeva Pinto, MD, Carlos Chiattone, MD PhD

Blood (2015) 126 (23): 5107.

https://doi.org/10.1182/blood.V126.23.5107.5107

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Non-GCB cell of origin leads to inferior outcomes in brazilian diffuse large B-cell lymphoma patients: Bra-DLBCL multicenter registry, retrospective study of over 500 patients

The impact of public versus private health care services in the treatment of diffuse large B-cell lymphoma in Brazil: An analysis from the bra-DLBCL multicenter, retrospective real-world registry

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Outcomes of diffuse large B-cell lymphoma and high-grade B-cell lymphoma in elderly patients aged ≥ 80 years-old treated in first line therapy: An analysis of the bra-DLBCL multicenter, real-world registry, retrospective study

Analysis of lymphoma subtypes, involved sites, and treatment outcomes in primary gastrointestinal B-cell lymphomas: A subset analysis within the PELÉ study of brazilian centers.

The impact of high-grade B-cell lymphoma morphology compared with diffuse large B-cell lymphoma in a cohort from bra-DLBCL, a multicenter, real-world study from Brazil

First-line venetoclax-based regimens versus chemoimmunotherapy in chronic lymphocytic leukemia: A real-world analysis from the brazilian CLL registry

Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.

Allogenic Transplant in Mycosis Fungoides: Never or Never Too Late?Brazilian Single Center Experience

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Adult T-Cell Leukemia/Lymphoma: A Cohort of 41 Cases Recorded in the Brazilian T-Cell Project

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Real Life CNS-IPI Score Validation: A Retrospective Analysis of Two Centers in Brazil Outside of Clinical Trial

Obinutuzumab for CLL Relapsed and Refractory Patients When New Oral Drugs an Not Available

IgA Levels Can Predict Survival in CLL Patients: A Retrospective Analysis of 183 Cases in a Brazilian Cohort

The Oral Mtor Inhibitor Everolimus in Relapsed and Refractory Hodgkin Lymphoma- Compassionate Use in 8 Centers in Brazil

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only